Literature DB >> 8218112

Regulation of endothelial cell tissue factor expression by minimally oxidized LDL and lipopolysaccharide.

H Fei1, J A Berliner, F Parhami, T A Drake.   

Abstract

Tissue factor (TF) is the predominant physiological initiator of coagulation, and its regulation is a critical aspect of endothelial cell hemostatic function. This report describes the regulation of TF mRNA expression by two physiological agonists: minimally oxidized low-density lipoprotein (MM-LDL), which may modulate endothelial hemostatic function in atherosclerosis, and lipopolysaccharide (LPS), which is a mediator of septic shock. Northern blot analysis of total RNA from human endothelial cells exposed to either MM-LDL or LPS for varying times showed that TF mRNA increased sharply at 1 hour, peaked at 2 to 3 hours, and declined to basal levels by 6 to 8 hours after treatment. The half-life of TF mRNA in MM-LDL- and LPS-exposed endothelial cells was approximately 45 minutes and 40 minutes, respectively. The rate of TF mRNA degradation was similar at 1 and 4 hours after exposure in either MM-LDL- or LPS-stimulated endothelial cells. Nuclear runoff transcription assays showed a significantly increased rate of TF gene transcription in both MM-LDL- and LPS-exposed endothelial cells. Cycloheximide inhibited the induction of TF protein activity, but it enhanced the accumulation of TF mRNA in MM-LDL- and LPS-induced endothelial cells. These results indicated that regulation of TF expression by MM-LDL and LPS in human endothelial cells occurs principally at the level of gene transcription.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8218112     DOI: 10.1161/01.atv.13.11.1711

Source DB:  PubMed          Journal:  Arterioscler Thromb        ISSN: 1049-8834


  14 in total

1.  Acute Coronary Syndromes: Molecular Basis for Cardiac Risk Factors.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

2.  Oxidized low density lipoprotein inhibits lipopolysaccharide-induced binding of nuclear factor-kappaB to DNA and the subsequent expression of tumor necrosis factor-alpha and interleukin-1beta in macrophages.

Authors:  B G Ohlsson; M C Englund; A L Karlsson; E Knutsen; C Erixon; H Skribeck; Y Liu; G Bondjers; O Wiklund
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

3.  Transcriptional regulation of endothelial cell tissue factor expression during Rickettsia rickettsii infection: involvement of the transcription factor NF-kappaB.

Authors:  R J Shi; P J Simpson-Haidaris; N B Lerner; V J Marder; D J Silverman; L A Sporn
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

4.  Chronic hyperglicemia and nitric oxide bioavailability play a pivotal role in pro-atherogenic vascular modifications.

Authors:  Assunta Pandolfi; Elena Anna De Filippis
Journal:  Genes Nutr       Date:  2007-10-17       Impact factor: 5.523

5.  Lipoproteins modulate expression of the macrophage scavenger receptor.

Authors:  J Han; A C Nicholson
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

Review 6.  Endothelial dysfunction and atherothrombotic occlusive disease.

Authors:  J E Freedman; J Loscalzo
Journal:  Drugs       Date:  1997       Impact factor: 9.546

7.  The statin-iron nexus: anti-inflammatory intervention for arterial disease prevention.

Authors:  Leo R Zacharski; Ralph G DePalma; Galina Shamayeva; Bruce K Chow
Journal:  Am J Public Health       Date:  2013-02-14       Impact factor: 9.308

Review 8.  Generation and biological activities of oxidized phospholipids.

Authors:  Valery N Bochkov; Olga V Oskolkova; Konstantin G Birukov; Anna-Liisa Levonen; Christoph J Binder; Johannes Stöckl
Journal:  Antioxid Redox Signal       Date:  2010-04-15       Impact factor: 8.401

9.  Highly electronegative LDL from patients with ST-elevation myocardial infarction triggers platelet activation and aggregation.

Authors:  Hua-Chen Chan; Liang-Yin Ke; Chih-Sheng Chu; An-Sheng Lee; Ming-Yi Shen; Miguel A Cruz; Jing-Fang Hsu; Kai-Hung Cheng; Hsiu-Chuan Bonnie Chan; Jonathan Lu; Wen-Ter Lai; Tatsuya Sawamura; Sheng-Hsiung Sheu; Jeng-Hsien Yen; Chu-Huang Chen
Journal:  Blood       Date:  2013-09-12       Impact factor: 22.113

Review 10.  Cellular expression and biological activities of alternatively spliced forms of tissue factor pathway inhibitor.

Authors:  Susan A Maroney; Karen G Hansen; Alan E Mast
Journal:  Curr Opin Hematol       Date:  2013-09       Impact factor: 3.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.